SR618

Lower channel breakout bounce.

看多
SR618 已更新   
NASDAQ:HRTX   Heron Therapeutics, Inc.
3
Low risk buy area. breaking out from lower regression channel w/divergence and volume. $15 will be some resistance, but after that could easily make it to $18.
評論:
finding resistance from the 20 and 50 ma. if can break that then this thing could get a decent pop.
評論:
seems that other sources say earnings are still in a week or so. so its looking good.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。